Kromek Regulatory News (KMK)

19 December 2022 

Kromek Group plc 

("Kromek" or the "Group") 

Kromek enters further agreement with Smiths Detection

Significant expansion of agreement to include distribution of Kromek's radiation detection solutions in the Middle East and certain markets in Asia and Australasia

Kromek Group plc (AIM: KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, is pleased to announce that it has entered into a distribution agreement with Smiths Detection, a global leader in threat detection and security screening technologies.

Under the terms of the agreement, Smiths Detection will market and distribute the Group's wearable radiation detection and identification solutions in the Middle East and certain key markets in Asia and Australasia. This expands the Group's existing agreement, as announced on 7 July 2022, with Smiths Detection Inc. for distribution in North and South American markets. To date, the Group has delivered over 1,000 detectors under this partnership.

Arnab Basu, CEO of Kromek Group, said: "We are pleased to be expanding our agreement with Smiths Detection to include the distribution and marketing of our solutions to the Middle East and parts of Asia and Australasia. This underscores the strength of our relationship and is a great endorsement of our products. With security forces globally requiring increasingly sophisticated solutions to guard against the threats of nuclear terrorism and the illicit movement of materials, the demand for our high-performance nuclear security products continues to grow."

Michael Lea, Global Director Defence of Smiths Detection, added "Smiths Detection are delighted to have entered into an agreement with Kromek to distribute their world-class products. We believe that they will meet the requirements of many customers across many different markets and will add a new dimension to the range of products available from Smiths Detection."

ENDS

For further information, please contact: 

Kromek Group plc 

Kromek Group plc is a leading developer of radiation detection and bio-detection technology solutions for the advanced imaging and CBRN detection segments. Headquartered in County Durham, UK, Kromek has manufacturing operations in the UK and US, delivering on the vision of enhancing the quality of life through innovative detection technology solutions.  

The advanced imaging segment comprises the medical (including CT and SPECT), security and industrial markets. Kromek provides its OEM customers with detector components, based on its core cadmium zinc telluride (CZT) platform, to enable better detection of diseases such as cancer and Alzheimer's, contamination in industrial manufacture and explosives in aviation settings.  

In CBRN detection, the Group provides nuclear radiation detection solutions to the global homeland defence and security market. Kromek's compact, handheld, high-performance radiation detectors, based on advanced scintillation technology, are primarily used to protect critical infrastructure and urban environments from the threat of 'dirty bombs'.  

The Group is also developing bio-security solutions in the CBRN detection segment. These consist of fully automated and autonomous systems to detect a wide range of airborne pathogens.  

Kromek is listed on AIM, a market of the London Stock Exchange, under the trading symbol 'KMK'.  

Further information is available at www.kromek.com.